NCT01728805 2024-04-25Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCLKyowa Kirin Co., Ltd.Phase 3 Completed372 enrolled 14 charts 1 FDA
NCT00002663 2023-02-13Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or MalignanciesAtara BiotherapeuticsPhase 1/2 Completed58 enrolled 18 charts
NCT00490776 2021-08-18Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)NovartisPhase 2 Terminated9 enrolled 6 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts